SALLY SUSMAN - 23 Feb 2022 Form 4 Insider Report for PFIZER INC (PFE)

Role: Executive Vice President
Signature: Susan E. Grant, by power of atty., for Sally Susman
Issuer symbol: PFE
Transactions as of: 23 Feb 2022
Net transactions value: -$745,093
Form type: 4
Filing time: 25 Feb 2022, 17:29:37 UTC
Previous filing: 30 Nov 2021
Next filing: 01 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PFE	Common Stock	Options Exercise	$2,102,309	+76,895	+86%	$27.34	166,470	23 Feb 2022	Direct	F1
transaction	PFE	Common Stock	Tax liability	$895,686	-19,110	-11%	$46.87	147,360	23 Feb 2022	Direct	F2
transaction	PFE	Common Stock	Tax liability	$1,951,717	-38,060	-26%	$51.28	109,300	23 Feb 2022	Direct	F3, F4
holding	PFE	Common Stock						746	23 Feb 2022	By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Stock Appreciation Rights	Options Exercise	$0	-76,895	-100%	$0.000000^*	0	23 Feb 2022	Common Stock	76,895	$27.34	Direct
transaction	PFE	Stock Appreciation Rights	Award	$0	+40,151		$0.000000	40,151	24 Feb 2022	Common Stock	40,151	$45.96	Direct	F5
transaction	PFE	Stock Appreciation Rights	Award	$0	+35,313		$0.000000	35,313	24 Feb 2022	Common Stock	35,313	$45.96	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2	The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3	The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4	Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F5	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F6	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.